606 - What Happens Next with Mifepristone?
Public Health On Call
The Johns Hopkins Bloomberg School of Public Health
4.6 • 644 Ratings
🗓️ 28 April 2023
⏱️ 24 minutes
🧾️ Download transcript
Summary
To understand what happens now that SCOTUS has stayed Judge Matthew Kacsmaryk's ruling on mifepristone, we first have to understand how the case got to the highest court in the land in the first place. Public health lawyer Joanne Rosen returns to the podcast to talk with Dr. Josh Sharfstein about the unprecedented series of filings and rulings around mifepristone from Amarillo, Texas to Washington D.C., and what could happen next as litigation continues to play out.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health, |
| 0:05.9 | where we bring evidence, experience, and perspective to make sense of today's leading health challenges. |
| 0:16.3 | If you have questions or ideas for us, please send an email to public health question at jh.h.u. |
| 0:23.6 | That's public health question at jhhu.edu for future podcast episodes. |
| 0:29.6 | This is Lindsay Smith Rogers. Today, Johns Hopkins legal expert Joanne Rosen joins Josh Sharfstein to look back on the recent court decisions on Mitha |
| 0:38.8 | Pristone, the drug used widely for medication abortion. Then they look ahead to what's next. |
| 0:45.4 | Let's listen. |
| 0:47.7 | Joanne Rosen, thank you so much for joining me on public health on call. We're here to talk about |
| 0:52.7 | Mitha Pristone and the Supreme Court. It has been |
| 0:55.9 | quite a week, hasn't it? It really has, yes. Let's go back to where this started in a Texas courtroom, |
| 1:06.5 | and then we'll talk about how it made its way to the Supreme Court. Sure. |
| 1:15.6 | So as we both know, the Dobbs' opinion came down in June. |
| 1:22.4 | And in around August of 2022, this organization known as the Alliance for Hippocratic Medicine, |
| 1:30.5 | it consists of a group of anti-abortion medical associations and physicians incorporated in Amarillo, Texas. And then in November, filed this claim, really an unprecedented claim |
| 1:36.8 | in Amarillo, in which they were alleging that the FDA's original approval of Mithopristone back in 2000, and then some of the FDA's |
| 1:47.6 | subsequent decisions with respect to the availability and conditions around Mithopristone |
| 1:53.4 | were essentially, for a number of reasons, unlawful, and they were seeking the revocation |
| 1:59.9 | of those approvals and therefore the removal of |
| 2:02.8 | Mifapristone from the market. Now, they selected Amarillo not by throwing a dart at a map. |
| 2:10.6 | That's correct. Now, they've argued that they incorporated in Amarillo because they had some ties to Amarillo. But the way that the |
| 2:19.4 | Northern District of Texas, the federal court, Northern District of Texas works, is that there |
| 2:24.6 | are some locales in which there are only single judges assigned to those locales. And Amarillo is |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.